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Abstract 
There is a large inter-individual variation in intrinsic sensitivity in patients receiving 
treatment with DNA damaging agents.  Cancer therapy exemplifies this problem 
where patients experience varying degree of normal tissue side effects in response to 
radiation or chemotherapy.  For this reason, it is necessary to develop an assay to 
predict sensitivity of a patient prior to treatment with DNA damaging agents.  This 
may allow more individualized treatment and improve the therapeutic index.  In paper 
I and II we focused on developing and validating a flow cytometry - based cell 
division assay (CD) that uses the thymidine analogue EdU (5-ethynyl-2’-
deoxyuridine) to measure the proliferative ability after DNA damaging treatment.  In 
paper I, the CD assay measured sensitivity to radiation of human skin fibroblasts with 
a correlation similar to the standard clonogenic survival assay in a relatively short time 
frame.  Using the easily sampled peripheral blood lymphocytes, the CD assay found 
variation in intrinsic sensitivity to radiation and detected increased sensitivity in 
patients with DNA repair defects.  In paper II, the CD assay was further validated for 
measurement of cell sensitivity to DNA damaging drugs.  The results indicated that 
the assay can be used to identify sensitive patients.  
 
Exposure to ionizing radiation generates free radicals that carry out most part of the 
toxic effects.  The cellular antioxidant system regulated by the Nrf2 transcription 
factor plays a key role in protecting cells against radical induced damage; hence in 
paper III we have investigated if pretreating cells with Nrf2 activators influence the 
sensitivity to radiation.  Results from paper III demonstrated that repeated treatment 
using the isothiocyanate sulforaphane protected human skin fibroblasts from toxic 
effects of ionizing radiation in an Nrf2-dependent manner.  In paper IV we found that 
repeated pretreatment of cells with Nrf2 activators, sulforaphane or synthetic 
triterpenoid bardoxolone methyl trained the cells to acquire resistance against higher 
toxic concentrations of both drugs.  Together these results indicate that repeated 
stimulation of Nrf2 system can enhance cytoprotection and that adaptation to stress 
may be a general feature of the Nrf2 response mechanism. 
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